Flemming Bager
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
- Food Science 15
- Salmonella and Campylobacter epidemiology 13
-
- Antimicrobial Resistance in Staphylococcus 8
- Co-authors
- Frank M. Aarestrup (17 shared papers)Henrik Caspar Wegener (14 shared papers)M. Madsen (4 shared papers)Hanne‐Dorthe Emborg (4 shared papers)E Jacobsen (2 shared papers)Anne Mette Seyfarth (2 shared papers)Karl Pedersen (2 shared papers)René S. Hendriksen (1 shared paper)
- Journals
- Preventive Veterinary Medicine (5 papers)Eurosurveillance (3 papers)Emerging infectious diseases (3 papers)Microbial Drug Resistance (3 papers)Apmis (2 papers)
- Partner nations
- DenmarkSlovakiaUnited Kingdom
In The Last Decade
Flemming Bager
33 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 113
- Molecular Medicine 682
- Applied Microbiology and Biotechnology 196
- Food Science 1.4k
- Pollution 725
- Endocrinology 295
Countries citing papers authored by Flemming Bager
This map shows the geographic impact of Flemming Bager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flemming Bager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flemming Bager more than expected).
Fields of papers citing papers by Flemming Bager
This network shows the impact of papers produced by Flemming Bager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flemming Bager. The network helps show where Flemming Bager may publish in the future.
Co-authors
The 25 scholars most cited alongside Flemming Bager, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 455 | |
| 2 | 1997 | 322 | |
| 3 | 2003 | 247 | |
| 4 | 1999 | 205 | |
| 5 | 1995 | 195 | |
| 6 | 1997 | 183 | |
| 7 | 1998 | 179 | |
| 8 | 1998 | 164 | |
| 9 | 2004 | 163 | |
| 10 | 2007 | 160 | |
| 11 | 2002 | 153 | |
| 12 | 2003 | 130 | |
| 13 | 1999 | 107 | |
| 14 | 1998 | 106 | |
| 15 | Transfer of antibiotic resistant bacteria from animals to man. | 1999 | 85 |
| 16 | 2000 | 81 | |
| 17 | 1996 | 81 | |
| 18 | 2000 | 54 | |
| 19 | DANMAP 2001: Use of antimicrobial agents and occurence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark | 2002 | 37 |
| 20 | 2002 | 35 |
About Flemming Bager
Flemming Bager is a scholar working on Food Science, Infectious Diseases, Pollution, Microbiology and Small Animals, having authored 33 papers that have together received 3.3k indexed citations. Recurring topics across this work include Salmonella and Campylobacter epidemiology (13 papers), Antimicrobial Resistance in Staphylococcus (8 papers), Pharmaceutical and Antibiotic Environmental Impacts (8 papers), Microbial infections and disease research (7 papers), Antibiotic Resistance in Bacteria (6 papers), Veterinary medicine and infectious diseases (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Antibiotic Use and Resistance (2 papers). The work is most often cited by research in Molecular Medicine (682 citations), Applied Microbiology and Biotechnology (196 citations), Food Science (1.4k citations), Pollution (725 citations) and Endocrinology (295 citations). Flemming Bager has collaborated with scholars based in Denmark, Slovakia and United Kingdom. Frequent co-authors include Frank M. Aarestrup, Henrik Caspar Wegener, M. Madsen, Hanne‐Dorthe Emborg, E Jacobsen, Anne Mette Seyfarth, Karl Pedersen, René S. Hendriksen, Vibeke Frøkjær Jensen and Mogens Madsen. Their work appears in journals such as Preventive Veterinary Medicine, Eurosurveillance, Emerging infectious diseases, Microbial Drug Resistance and Apmis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.